Intravesical capsaicin for treatment of severe bladder pain: A randomized placebo controlled study

被引:68
作者
Lazzeri, M [1 ]
Beneforti, P [1 ]
Benaim, G [1 ]
Maggi, CA [1 ]
Lecci, A [1 ]
Turini, D [1 ]
机构
[1] A MENARINI INST,DEPT PHARMACOL,FLORENCE,ITALY
关键词
capsaicin; bladder diseases; pain;
D O I
10.1016/S0022-5347(01)65669-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Present therapeutic approaches to control bladder pain are clinically and scientifically unsatisfactory, and pain in the lower urinary tract remains a challenge even to the skilled urologist. A randomized placebo controlled study was done to evaluate intravesical capsaicin for severe bladder pain. Followup was 6 months. Materials and Methods: A total of 36 patients was prospectively randomized into those receiving 10 mu M. intravesical capsaicin twice weekly for 1 month (group 1) or placebo (group 2). All patients had pelvic pain for at least 6 months, and had no urinary tract infection within the last 3 months, functional disorders of the lower urinary tract, or other vesical or urethral pathology. Pretreatment voiding pattern and pain score were recorded. Patients were evaluated immediately at the end of treatment (primary end point) and 6 months later (secondary end point). Results: Both groups were adequately homogeneous with regard to age, sex ratio, duration of disease, voiding pattern and pain score. At both end points group 1 had significant improvement in frequency and nocturia but no improvement in urgency. No change was noted in group 2. A significant decrease in pain score was found in group 1 at the primary (mean plus or minus standard deviation 3.22 +/- 0.42, p <0.01) and secondary (3.83 +/- 0.47, p <0.01) end points compared to before treatment (5.61 +/- 0.40, chi-square with 2 degrees of freedom 29.25, p <0.0001). A significant improvement was also observed in the placebo group, in which the pretreatment pain score (5.47 +/- 0.37) was decreased at the primary (4.47 +/- 0.36, p <0.01) and secondary (4.48 +/- 0.34, p <0.01, chi-square with 2 degrees of freedom 12.71, p <0.002) ena points. There were no statistically significant differences between the 2 groups. Conclusions: We confirmed the beneficial effect of intravesical instillation of capsaicin on voiding pattern in patients with hypersensitive disorders (frequency and nocturia). We could not confirm improvement in pain score after capsaicin treatment compared to placebo. Possibly a larger dose of capsaicin would be more effective in controlling pain and neurological disease of the bladder.
引用
收藏
页码:947 / 952
页数:6
相关论文
共 28 条
  • [1] ALBELLI L, 1989, J UROLOGY, V141, P148
  • [2] RELIEF OF PAIN FOLLOWING INTRAVESICAL CAPSAICIN IN PATIENTS WITH HYPERSENSITIVE DISORDERS OF THE LOWER URINARY-TRACT
    BARBANTI, G
    MAGGI, CA
    BENEFORTI, P
    BAROLDI, P
    TURINI, D
    [J]. BRITISH JOURNAL OF UROLOGY, 1993, 71 (06): : 686 - 691
  • [3] PELVIC PAIN WITHOUT PELVIC ORGANS
    BASKIN, LS
    TANAGHO, EA
    [J]. JOURNAL OF UROLOGY, 1992, 147 (03) : 683 - 686
  • [4] BLACKWELL B, 1972, LANCET, V1, P1279
  • [5] BUCKALEW LW, 1982, J CLIN PSYCHOPHARM, V2, P245
  • [6] CHAHL LA, 1984, ANTIDROMIC VASODILAT
  • [7] PEPPERING PAIN
    CLARKE, IMC
    [J]. LANCET, 1993, 342 (8880) : 1130 - 1130
  • [8] THERAPEUTIC POTENTIAL OF CAPSAICIN-LIKE MOLECULES - TREATMENT PARAMETERS OF DESENSITIZATION TO CAPSAICIN
    CRAFT, RM
    PORRECA, F
    [J]. LIFE SCIENCES, 1992, 51 (23) : 1767 - 1775
  • [9] DUKE W, 1922, SURG GYNECOL OBSTET, V35, P759
  • [10] DYMOND EC, 1960, AM J CARDIOL, V5, P483